Olema Pharmaceuticals share price logo

Olema Pharmaceuticals

NASDAQ: OLMA

Small Cap

$10.69

-0.21

(-1.93%)

as on

Olema Pharmaceuticals Stock Performance

as on August 22, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $10.65
    $11.24
    downward going graph

    0.37%

    Downside

    5.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.34
    $36.26
    downward going graph

    50.05%

    Downside

    239.19%

    Upside

    downward going graph

Olema Pharmaceuticals share price movements today

Previous Close
$10.90
Open
$10.84
Volume
667.2K
Market Cap
$930.1M
Day's Low - High
$10.65 - $11.24
52 Week Low - High
$5.34 - $36.26

Olema Pharmaceuticals Historical Returns

1 Month Return
-7.32 %
3 Month Return
-21.78 %
1 Year Return
+ 92.92 %
3 Year Return
+ 21.07 %
5 Year Return
-60.63 %

Olema Pharmaceuticals Stock Fundamentals & Key Indicators

Check Olema Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$930.1M

EPS (TTM)

-2.3875

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-220.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-52.74%

Olema Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Olema Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$930.1M-60.63%NA0.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Olema Pharmaceuticals Stock including INR - Dollar returns

The Olema Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Olema Pharmaceuticals investment value today

Current value as on today

₹2,12,661

Returns

₹1,12,661

(+112.66%)

Returns from Olema Pharmaceuticals Stock

₹94,011 (+94.01%)

Dollar Impact

₹18,650 (+18.65%)

Analyst Recommendation on Olema Pharmaceuticals Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Olema Pharmaceuticals. Average target price of $40.2

Olema Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Olema Pharmaceuticals.

What analysts predicted

73.41%UPSIDE

Target Price

$40.2

Current Price

$10.69

Analyzed by

9 Analysts

Target

$40.20

Olema Pharmaceuticals target price $40.2, a slight upside of 73.41% compared to current price of $10.69. According to 9 analysts rating.

Indian Investors' Interest in Olema Pharmaceuticals Stock

Search interest for Olema Pharmaceuticals Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Olema Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
-
0
0
Operating Income
-34
-33
-37
-36
-34
-47
-45
-50
-57
EBITDA
-30
-30
-34
-33
-30
-43
-42
-45
-52
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-30
-30
-34
-33
-30
-43
-42
-46
-53
Income Tax Expense
-3
-
-
3
-
-
-
-
-
Net Income
-30
-30
-34
-33
-30
-43
-42
-46
-53
Net Profit Margin
0.00%
0.00%
0.00%
-9221.70%
0.00%
0.00%
0.00%
0.00%
0.00%

Olema Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-1
-1
0
0
-
Operating Income
-2
-4
-21
-71
-106
-104
-142
-178
EBITDA
-2
-4
-21
-70
-106
-96
-129
-161
Interest Expense
0
-
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-2
-4
-22
-71
-104
-96
-129
-162
Income Tax Expense
0
0
0
0
-2
-
0
-
Net Income
-2
-4
-22
-71
-102
-96
-129
-162
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Olema Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-30
-34
-33
-30
-43
-42
-46
-53
-63
Operating Cash Flow
-27
-27
-26
-43
-29
-34
-38
-45
-45
Investing Cash Flow
-4
45
-114
-45
34
17
-162
4
40
Financing Cash Flow
15
0
244
0
-2
0
213
45
1
Change in Cash
-16
18
103
-88
1
-17
13
4
-3

Olema Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-22
-71
-104
-96
-129
-162
Operating Cash Flow
-3
-19
-50
-82
-83
-104
-146
Investing Cash Flow
0
0
-275
91
-4
-93
-155
Financing Cash Flow
358
358
1
0
133
268
211
Change in Cash
-3
338
-324
9
44
70
-91

Mutual Funds that own Olema Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Olema Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.437652%
3007864
Fidelity Select Portfolios
2.335035%
2043100
Fidelity Securities Fund
1.817764%
1590500
Fidelity Advisor Series VII
1.745419%
1527200
Fidelity Concord Street Trust
1.355218%
1185784

Global Institutional Holdings in Olema Pharmaceuticals

Funds
Holdings
Vanguard
4.52%
iShares
4.39%
SPDR
3.46%
Peter Kolchinsky
2.97%
Michael Rockefeller
1.69%

Olema Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 09 March

    Mon, 09:52 PM

    -

    Olema Pharmaceuticals shares fell 20.46% after Roche's trial results failed to meet primary objectives.

Insights on Olema Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 380.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 586.8% return, outperforming this stock by 574.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, OLMA stock has moved down by -55.6%

About Olema Pharmaceuticals

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic ER-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivotal Phase 3 clinical trial of palazestrant as a monotherapy in second/third-line ER+/HER2- metastatic breast cancer; and palazestrant with CDK4/6 inhibitors, a phosphatidylinositol 3 kinase alpha (PI3Ka) inhibitor alpelisib, a mechanistic target of rapamycin inhibitor, and a CDK4 inhibitor that is in Phase 1b/2 clinical trial for the treatment of ER+/HER2- advanced or metastatic breast cancer. It also develops OP-3136, an orally-available small molecule that potently and selectively inhibits KAT6 which is in Phase 1 clinical trials for patients with breast and other solid tumor cancers. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
OrganisationOlema Pharmaceuticals
Headquarters780 Brannan Street, San Francisco, CA, United States, 94103
IndustryBiotechnology
CEOMs. Shawnte M. Mitchell J.D.
E-voting on sharesClick here to vote

Key Management of Olema Pharmaceuticals

Name

Title

Ms. Shawnte M. Mitchell J.D.

Chief Legal Officer & Corporate Secretary

FAQs

What is Olema Pharmaceuticals share price today?

Olema Pharmaceuticals share price today is $10.69 as on at the close of the market. Olema Pharmaceuticals share today touched a day high of $11.24 and a low of $10.65.

What is the 52 week high and 52 week low for Olema Pharmaceuticals share?

Olema Pharmaceuticals share touched a 52 week high of $36.26 on and a 52 week low of $5.34 on . Olema Pharmaceuticals stock price today i.e. is closed at $10.69,which is 70.52% down from its 52 week high and 100.19% up from its 52 week low.

What is Olema Pharmaceuticals's market capitalisation today?

Olema Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Olema Pharmaceuticals Stock (OLMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Olema Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Olema Pharmaceuticals Shares that will get you 0.1403 shares as per Olema Pharmaceuticals share price of $10.69 per share as on August 22, 2026 at 8:45 am IST.

What is the minimum amount required to buy Olema Pharmaceuticals Stock (OLMA) from India?

Indian investors can start investing in Olema Pharmaceuticals (OLMA) shares with as little as ₹95.685 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.85 in Olema Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Olema Pharmaceuticals share’s latest price of $10.69 as on August 22, 2026 at 8:45 am IST, you will get 0.9355 shares of Olema Pharmaceuticals. Learn more about fractional shares .

What are the returns that Olema Pharmaceuticals has given to Indian investors in the last 5 years?

Olema Pharmaceuticals stock has given -60.63% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?